• Vaccines, Biden administration supports patent revocation.

    Von der Leyen: "Europe ready to discuss it"

  • Biden's breakthrough on vaccine patents.

    Roberto Speranza: "Europe also does its part"

  • State of the Union, von der Leyen: "Italy asked the EU to intervene and it was right"

  • Covid, about 2.5 million vaccines are being delivered

Share

06 May 2021 "Vaccines are a global common good. It is a priority to increase their production, guaranteeing their safety, and breaking down the obstacles that limit vaccination campaigns". So we read in a note from the Prime Minister, Mario Draghi.



Draghi's intervention is closely linked, representing a clear and new stance by the Italian government, to the moratorium on the patents of anticovid vaccines that the American president, Joe Biden, wants. And it follows the statements made by the president of the European Commission, Ursula von der Leyen, precisely about the possibility of making vaccine patents a common good.



The American input

The stance of the American government to make available to the global community the two vaccines that more than any other have shown not only to be effective and safe, but also to be flexible enough to be able to respond to the possible emergence of new variants of the virus that could reignite, at any moment, the pandemic, represents an epochal act.



Potentially it is a real reversal of the global geopolitical framework, with the United States returning to the scene with all its economic, technological and scientific power and looking at the fight against the pandemic with a global perspective that focuses on security.



Europe present

A proposal immediately endorsed by the European Union. "We are willing to discuss how the US proposal for a waiver of intellectual rights protection for Covid vaccines that could help" fight the pandemic globally, said European Commission President Ursula von der Leyen. during the speech on the State of the Union.



Italy's commitment

In this wake, Mario Draghi's brief statement opens up a commitment by Italy and a new path, so that countries like India can begin to see the light at the end of the tunnel. For this to be possible, however, the European Union and the member states that have so far opposed the suspension of the Big Pharma monopolies, must change course. The Italian Parliament has already given the Government an indication in this direction, Draghi's note now points decisively towards the objective.